Upendra Kaul

Last updated

Upendra Kaul
Born
India
Occupation Cardiologist
Known for Interventional cardiology
Awards Padma Shri
Dr. B. C. Roy Award
Medtronic Award
CSI Searle Award
ICMR Shakuntala Amirchand Prize
Press India Award

Upendra Kaul is an Indian cardiologist and one of the pioneers of interventional cardiology in India. [1] He is the Chairman and Dean Academics and Research at the Batra Hospital and Medical Research Center. [2] He is known for his expertise in procedures such as Percutaneous Cardiopulmonary bypass, Rotational and Directional Atherectomy, Coronary stenting and Percutaneous Laser Myocardial Revascularization. [3] He graduated in medicine (MBBS) from the Maulana Azad Medical College and continued his studies at the same institution to secure MD in 1975 and, DM in cardiology in 1978. [4] Later, he obtained advanced training in interventional cardiology from Australia during 1983 to 84. He has served the All India Institute of Medical Sciences (AIIMS) as a professor of cardiology and has been a member of the faculty of the Post Graduate Institute of Medical Education and Research, G. B. Pant Hospital, Batra Hospital and Fortis Health Care, NCR. [2] and Executive Director and Dean at Fortis Health Care, New Delhi.

Contents

Kaul is a former president of the Cardiological Society of India and the SAARC Cardiac Society [5] and is a Fellow of the American College of Cardiology and the National Academy of Medical Sciences (NAMS). [2] He has published over 450 medical papers [4] [6] and has won the Medtronic Award for the Best Scientific Paper in 1983. [3] He received the highest Indian award in the medical category, Dr. B. C. Roy Award, in 1999. [2] [4] The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2006, for his contributions to Indian medicine. [7] He is also a recipient of the Dr. Thapar Gold Medal in 1970, Searle Award of the Cardiological Society of India in 1986, Shakuntala Amirchand Prize of the Indian Council of Medical Research in 1987, Press India Award in 1992. [3]

In 2019, he was summoned by the National Investigation Agency (NIA) after the NIA sleuths misread his use of medical jargon to mean a hawala transaction. [8] , Prof Kaul started an NGO Gauri Kaul Foundation (registered with the Ministry of Corporate Affairs (MCA), bearing DIN 09139657) in April 2021. The foundation has set up 3 centres in Jammu and Kashmir, Machil, near LOC, District Kupwara, Jagti Migrant township near Nagrota Jammu and in his place of birth Hawal, Pulwama. Indian Oil Corporation (IOC) and Oil and Natural Gas Corporation (ONGC) and Astra Zeneca have generously helped through their CSR. Currently their mission is "No Heart attack" by spreading measures to be taken by the public at large by organizing public awareness programs. Prof Kaul has written his memoirs "When The Heart Speaks" published by Konark publishing house in September 2022.

See also

Related Research Articles

<span class="mw-page-title-main">Angioplasty</span> Procedure to widen narrow arteries or veins

Angioplasty, also known as balloon angioplasty and percutaneous transluminal angioplasty (PTA), is a minimally invasive endovascular procedure used to widen narrowed or obstructed arteries or veins, typically to treat arterial atherosclerosis. A deflated balloon attached to a catheter is passed over a guide-wire into the narrowed vessel and then inflated to a fixed size. The balloon forces expansion of the blood vessel and the surrounding muscular wall, allowing an improved blood flow. A stent may be inserted at the time of ballooning to ensure the vessel remains open, and the balloon is then deflated and withdrawn. Angioplasty has come to include all manner of vascular interventions that are typically performed percutaneously.

<span class="mw-page-title-main">Interventional cardiology</span>

Interventional cardiology is a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Andreas Gruentzig is considered the father of interventional cardiology after the development of angioplasty by interventional radiologist Charles Dotter.

Hybrid coronary revascularization (HCR) or hybrid coronary bypass is a relatively new type of heart surgery that provides an alternative to traditional coronary artery bypass surgery (CABG) or percutaneous coronary intervention by combining the two into one operation. It is this combining aspect that "hybrid" refers to. HCR is one of several types of hybrid cardiac surgery; it is not to be confused with a MIDCAB procedure, which uses the smaller thoracotomy incision but does not involve coronary stenting.

<span class="mw-page-title-main">Percutaneous coronary intervention</span> Medical techniques used to manage coronary occlusion

Percutaneous coronary intervention (PCI) is a minimally invasive non-surgical procedure used to treat narrowing of the coronary arteries of the heart found in coronary artery disease. The procedure is used to place and deploy coronary stents, a permanent wire-meshed tube, to open narrowed coronary arteries. PCI is considered 'non-surgical' as it uses a small hole in a peripheral artery (leg/arm) to gain access to the arterial system, an equivalent surgical procedure would involve the opening of the chest wall to gain access to the heart area. The term 'coronary angioplasty with stent' is synonymous with PCI. The procedure visualises the blood vessels via fluoroscopic imaging and contrast dyes. PCI is performed by an interventional cardiologists in a catheterization laboratory setting.

<span class="mw-page-title-main">Drug-eluting stent</span> Medical stent that releases drug

A drug-eluting stent (DES) is a thin tube that is used to treat narrowed arteries in medical procedures. It releases drugs to prevent the growth of scar tissue and reduce the risk of stent restenosis, which is the narrowing of the stented area of an artery after treatment. A drug-eluting stent is different from other types of stents because it has a coating that delivers medication directly to the arterial wall. A DES is often made of metal alloys and can be inserted into blocked or narrowed arteries through a catheter placed in a peripheral artery, such as in the arm or leg. DES is fully integrated with a catheter delivery system and is viewed as one integrated medical device.

<span class="mw-page-title-main">Maulana Azad Medical College</span> Medical College in Delhi

Maulana Azad Medical College (MAMC) is a medical college in New Delhi, India affiliated to University of Delhi and run by the Delhi government. It is named after Indian freedom fighter and first education minister of independent India Maulana Abul Kalam Azad. It was established in 1959 at Bahadur Shah Zafar Marg near Delhi Gate.

The history of invasive and interventional cardiology is complex, with multiple groups working independently on similar technologies. Invasive and interventional cardiology is currently closely associated with cardiologists, though the development and most of its early research and procedures were performed by diagnostic and interventional radiologists.

<span class="mw-page-title-main">Coronary stent</span> Medical stent implanted into coronary arteries

A coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in patients suffering from coronary heart disease. The vast majority of stents used in modern interventional cardiology are drug-eluting stents (DES) It is used in a medical procedure called percutaneous coronary intervention (PCI). Coronary stents are divided into two broad types - drug-eluting and bare metal stents, as of 2023 drug-eluting stents were used in more than 90% of all PCI procedures. Stents reduce angina and have been shown to improve survival and decrease adverse events after a patient has suffered a heart attack - medically termed an acute myocardial infarction.

<span class="mw-page-title-main">Praveen Chandra</span> Indian cardiologist

Dr. Praveen Chandra is an Indian cardiologist and chairman of interventional cardiology at Medanta - The Medicity, Gurgaon, India. He is recognised as one of the leaders in angioplasty in the country and is proficient in a lot of new devices and technologies. He has been awarded for his contribution and services in the field of coronary angioplasty in India in 1998.

Govindan Vijayaraghavan is a cardiologist from India, credited with establishing the first 2D Echocardiography laboratory in India. He is the vice-chairman & Founder Director of the Kimshealthcare Trivandrum and the President of the Society for Continuing Medical Education and Research, Trivandrum, Kerala. He was honoured by Government of India in 2009 for his services in the field of medical sciences by awarding him Padmashri.

Mathew Samuel Kalarickal is an Indian cardiologist widely known as the father of angioplasty in India. He specializes in coronary angioplasty, carotid stenting, coronary stenting and rotablator atherectomy.

Bhupathiraju Somaraju, shortly B. Somaraju, is an Indian cardiologist and was the chairman of CARE Hospitals, Hyderabad. Author of many medical articles in peer reviewed journals and an elected fellow of the National Academy of Medical Sciences, he was honoured by the Government of India, in 2001, with the fourth highest Indian civilian award of Padma Shri.

<span class="mw-page-title-main">Ashok Seth</span> Indian interventional cardiologist

Ashok Seth is an Indian interventional cardiologist, credited with the performance of over 50,000 angiograms and 20,000 angioplasties, which has been included in the Limca Book of Records, a book for achievements and records from an Indian perspective. He is a Fellow of the Royal Colleges of Physicians of London, Edinburgh and Ireland and serves as the chief cardiologist, holding the chairs of the department of cardiovascular sciences and cardiology council at the Fortis Healthcare. Seth, a recipient of the Order of Isabella the Catholic, was honored by the Government of India with the fourth highest Indian civilian award of Padma Shri, in 2003, followed by Padma Bhushan, the third highest Indian civilian award, in 2015.

Harvinder Sahota is an Indian American cardiologist. He is the inventor of the FDA approved Perfusion Balloon Angioplasty known as "Sahota Perfusion Balloon".

Tarlochan Singh Kler is an Indian interventional cardiologist, medical administrator, writer, Chairman at Fortis Heart and Vascular Institute, and. Born in Amargarh in the Indian state of Punjab, he graduated in medicine from Punjabi University in 1976, secured his MD in general medicine from Postgraduate Institute of Medical Education and Research (PGIMER) in 1980 and followed it up with the degree of DM in cardiology from the same institution in 1983. He succeeded Naresh Trehan as the executive director of Fortis Heart Institute and Research Centre before becoming its director. He has written several articles on interventional cardiology; Persistent left superior vena cava opening directly into right atrium and mistaken for coronary sinus during biventricular pacemaker implantation, Mammary coronary artery anastomosis without cardiopulmonary bypass through minithoracotomy: one year clinical experience, and Ventricular Fibrillation in the EP Lab. What is the Atrial Rhythm? are some of the notable ones. The Government of India awarded him the third highest civilian honour of the Padma Bhushan, in 2005, for his contributions to medicine.

Daljeet Singh Gambhir is an Indian cardiologist, medical academic, researcher and inventor and the Group Director of Cardiology at Kailash Group of Hospitals and Heart Institute, Delhi. He is the inventor of Infinnium Paclitaxel-Eluting Stent, a reportedly cheaper drug-eluting stent which he first presented at the EuroPCR meeting held in Paris in 2003. A fellow of the National Academy of Medical Sciences and an honorary fellow of the Indian College of Cardiology, he is reported to have performed over 10,000 coronary interventions. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2016, for his contributions to medicine.

<span class="mw-page-title-main">Kamal Kumar Sethi</span>

Kamal Kumar Sethi is an Indian neurologist

Donald S. Baim was a researcher and clinician in the field of interventional cardiology. Baim's primary research focused on coronary blood flow, catheter intervention in heart disease, and congestive heart failure. His work helped to shift the use of catheters from a purely diagnostic tool to a therapeutic tool. After receiving a medical degree from Yale and initial medical training, residency and a fellowship at Stanford University Medical Center, Baim spent the bulk of his career at Beth Israel Hospital and at the Brigham and Women's Hospital in Boston. In 1993, Baim founded the Beth Israel Hospital's Cardiovascular Data Analysis Center (CDAC) -- later to be named Harvard Clinical Research Institute (HCRI). Baim died of cancer in November 2009. In October 2016, HCRI changed its name to the Baim Institute for Clinical Research.

<span class="mw-page-title-main">Samin Sharma</span> American interventional cardiologist

Samin K. Sharma is an American philanthropist of Indian descent and an interventional cardiologist who co-founded the Eternal Heart Care Centre and Research Institute in Jaipur (EHCC). Sharma has served on New York State’s Cardiac Advisory Board since 2004. As of 2021, he is Senior Vice-President, Operations & Quality at The Mount Sinai Hospital in New York and runs the Dr. Samin K. Sharma Family Foundation Cardiac Catheterization Laboratory. As of 2018, he is Chairman Board of Trustees, Association of Indians in America (AIA). As of 2022, he has been an investigator on 86 grants and multi-center trials and authored 486 peer-reviewed articles that have been cited 21,734 times.

Alfredo E. Rodríguez is an Argentine interventional cardiologist, clinical researcher, and author. He is the Chief of Interventional Cardiology Service at Otamendi Hospital and Director and Founder of the Cardiovascular Research Center (CECI) a non -profit Research Organization in Buenos Aires Argentina.

References

  1. "Doctor Profile". My Doc Advisor. 2015. Retrieved 13 December 2015.
  2. 1 2 3 4 "Expert Profile". ND TV. 2015. Retrieved 13 December 2015.
  3. 1 2 3 "Dr. Upendra Kaul Credihealth". Credihealth. 2015. Retrieved 13 December 2015.[ permanent dead link ]
  4. 1 2 3 "Dr Upendra Kaul - Medical Tourism Corporation". Medical Tourism Corporation. 2015. Retrieved 13 December 2015.
  5. "Executive Director - Academics & Research(Cardiology)". Fortis Hospitals. 2015. Retrieved 13 December 2015.
  6. Upendra Kaul; Sripal Bangalore; Ashok Seth; Priyadarshini Arambam; Rajpal K. Abhaychand; Tejas M. Patel; Darshan Banker; Atul Abhyankar; Ajit S. Mullasari; Sanjay Shah; Rajneesh Jain; Premchand R. Kumar; C.G. Bahuleyan (2015). "Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes". N Engl J Med. 373 (18): 1709–1719. doi: 10.1056/NEJMoa1510188 . PMID   26466202.
  7. "Padma Awards" (PDF). Ministry of Home Affairs, Government of India. 2015. Retrieved 21 July 2015.
  8. "OOPS: NIA Summons Padmashri Cardiologist after confusing his Medical Jargon to Hawala Funding". Medical Dialogues. 31 August 2019.